CUV 0.43% $15.02 clinuvel pharmaceuticals limited

Ann: SCENESSE European Orphan Drug Designation for VP, page-9

  1. 594 Posts.
    lightbulb Created with Sketch. 281
    It is however enlightening to see how much progress Clinuvel have made in VP in the 8 years since fda odd. None. Almost 5 years since fda epp approval. 200 million in the bank and no progress at all. Waiting for the right time I expect.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.